Evidence map›Paper›PMID 40485679›Full record

ArticleKidney international reports2025

Inducing

Sonia Fargue, Mangesh Suryavanshi, Kyle D Wood, Joseph J Crivelli, Robert A Oster, Dean G Assimos, Aaron Miller, John Knight

Abstract read
In one paragraph

Article in Kidney international reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Gut microbes · 2025
    Article
  7. Article
  8. Hyperoxaluria: Diagnosis and Treatment.The Urologic clinics of North America · 2025
    Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Sonia FargueDepartment of Urology, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Mangesh SuryavanshiCardiovascular and Metabolic Sciences Department, Cleveland Clinic, Cleveland, Ohio, USA.
Kyle D WoodDepartment of Urology, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Joseph J CrivelliDepartment of Urology, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Robert A OsterDivision of Preventive Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Dean G AssimosDepartment of Urology, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Aaron MillerCardiovascular and Metabolic Sciences Department, Cleveland Clinic, Cleveland, Ohio, USA.
John KnightDepartment of Urology, University of Alabama at Birmingham, Birmingham, Alabama, USA.

Funding

National Dissemination of I-Corps@NCATS: Accelerating Translation through CommercializationUL1TR003096 · NCATS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI GUTIERREZ, ORLANDO M, KIMBERLY, ROBERT P. · 2019 to 2023
$43.6M
Oxalobacter formigenes colonization and oxalate excretion in calcium oxalate kidney stone diseaseR01DK087967 · NIDDK · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI KNIGHT, JOHN · 2011 to 2020
$3.5M
The role of acetogenic, methanogenic, and sulfate-reducing bacteria in oxalate metabolism and hyperoxaluriaR01DK121689 · NIDDK · CLEVELAND CLINIC LERNER COM-CWRU · PI MILLER, AARON W · 2020 to 2024
$2.3M
Obesity and Endogenous Oxalate SynthesisK08DK115833 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI WOOD, KYLE D · 2018 to 2022
$960k
Effect of weight loss on urinary oxalate excretion in obese calcium oxalate kidney stone formersR01DK128160 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI ASSIMOS, DEAN GEORGE · 2021 to 2023
$944k
Assessment of Endogenous Oxalate Synthesis in Calcium Oxalate Kidney Stone Formers and Healthy IndividualsR03DK129497 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI FARGUE, SONIA · 2021 to 2022
$199k
NCATS NIH HHS UL1 TR003096NIDDK NIH HHS K08 DK115833NIDDK NIH HHS R01 DK087967NIDDK NIH HHS R01 DK121689NIDDK NIH HHS R01 DK128160NIDDK NIH HHS R03 DK129497
6 · The paper itself

Abstract

Introduction: Oxalate-degrading intestinal bacteria, including the oxalate-degrading specialist, Methods: Twenty-two healthy adults without a history of kidney stones and not colonized with Results: All 22 participants were successfully colonized after a single dose of Conclusion: These findings support future investigations to examine the effectiveness of

Indexed as

calcium oxalatehyperoxaluriakidney calculiOxalobacter formigenesprobiotics

Identifiers

PMID40485679
PMCPMC12142626

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.